A 50 year old Indiana man with glioblastoma multiforme, or GBM, has become the first such patient in North America to be prescribed a brand-new FDA treatment for the disease outside of clinical trial.
The treatment is called Tumor Treating Fields, a novel, non-invasive therapy that uses alternating electrical fields to disrupt rapid cell division, a hallmark of cancer cells.
The therapy is administered by trained and certified health professionals using the NovoTTF-100A System, a portable device made by Novocure.
The patient has already endured surgery, chemotherapy and radiation, to no avail. The therapy offers him a new alternative, as it does many of the 10,000 or so new GBM patients diagnosed in the United States each year.
Source: Medical News Today
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
